A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 207
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : TRAb
Long Form : thyrotropin receptor antibody
No. Year Title Co-occurring Abbreviation
2023 A retrospective study of clinical features and prognosis of patients with Graves' disease and ophthalmopathy. GD
2023 Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study. AITD, ALZ, ATDs, GD, HT, MS, RR
2022 Change of intraocular blood flow during treatment for thyroid eye disease. CAS, LSFG, OCTA, TED
2022 Consistency Between Thyrotropin Receptor Antibody (TRAb) and Thyroid-Stimulating Antibody (TSAb) Levels in Patients with Graves Disease. GD, TSAb
2022 Coronavirus as a Trigger Of Graves' Disease. ---
2022 Decreased serum interleukin-41/Metrnl levels in patients with Graves' disease. CRP, FT3, FT4, GD, IL, TgAb, TPOAb, TSH, WBC
2022 Emerging Insights Into the Role of Epigenetics and Gut Microbiome in the Pathogenesis of Graves' Ophthalmopathy. GD, GO, OFs, Th17
2022 Follow-Up of Thyroid Function in Children With Neonatal Hyperthyroidism. ATD, CeH, GD
2022 Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report. CT
10  2022 Outcomes of Early-Pregnancy Antithyroid Drug Withdrawal in Graves' Disease: A Preliminary Prospective Follow-Up Study. ATDs, OR
11  2022 Pleiomorphism plurihormonal Pit-1-positive macroadenoma with central hyperthyroidism: a rare case report and literature review. GH, IGF-1, MRI, PitNETs, PRL, SRL, TgAb, TPOAb, TSH
12  2022 Severe Hyperthyroidism and Complete Hydatidiform Mole in Perimenopausal Woman: Case Report and Literature Review. GTD
13  2022 The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves' Disease. AIDs, COVID-19, GD, SARS-CoV-2
14  2022 The Interactive Effects of Severe Vitamin D Deficiency and Iodine Nutrition Status on the Risk of Thyroid Disorder in Pregnant Women. CI, UIC
15  2022 Utility of Antibodies in the Diagnoses of Thyroid Diseases: A Review Article. Anti-TPO antibodies, CTLA, GD, HLA, HT, TPO, TSGT
16  2022 Xiehuo Xiaoying decoction inhibits Tfh cell expansion and promotes Tfr cell amplification to ameliorate Graves' disease. FOXP3, GD, HO-1, Keap1, Nrf2, OS, XHXY
17  2022 [Analysis of experience in diagnosis and treatment of fetal goiter in patients with Graves' disease complicated with pregnancy]. GD
18  2021 A Chinese survey on clinical practice in hyperthyroidism management: comparison with recent studies and guidelines. ATA, ATDs, RAIU
19  2021 A Longitudinal Study of Medial Temporal Lobe Volumes in Graves Disease. GD, MR, MTL
20  2021 A systematic review of euthyroid Graves' disease (Review). EGD
21  2021 Associations between gut microbiota and thyroidal function status in Chinese patients with Graves' disease. GD
22  2021 Autoimmune thyroid disease correlates to islet autoimmunity on zinc transporter 8 autoantibody. AITD, GADA, GD, HC, HT, IA-2A, T1DM, TgAb, TPOAb, ZnT8A
23  2021 Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy. BCVA, DON, ROC, SPECT/CT, TED, UR, VACI, VEP
24  2021 Correlation between thyroid autoantibodies and cardiovascular disease in patients with stages 3-5 chronic kidney disease. CKD, CVD, TPOAb
25  2021 Effects of animal protein intake during pregnancy on autoimmune thyroiditis in pregnant women with mild iodine deficiency. CI, TPOAb, UIC
26  2021 Effects of glucocorticoid pulse therapy on thyroid function and thyroid antibodies in children with graves' disease. GD, MPT, TgAb, TPOAb
27  2021 Evaluation of choroidal circulation and stromal features in Graves' disease. CT, CVI, GD, SA, TCA
28  2021 Evaluation of thyroid disease and thyroid malignancy in acromegalic patients. FNAC, GH, IGF, MNG, OR, US
29  2021 Expansion of inflammatory monocytes in periphery and infiltrated into thyroid tissue in Graves' disease. GD
30  2021 Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves' disease. AF, BMI, GD, HF, HFpEF, HFrEF
31  2021 Possibility analysis of thyroid imaging parameters for dose adjustment in 131I treatment of hyperthyroidism. ROI
32  2021 Probiotic Bifidobacterium longum supplied with methimazole improved the thyroid function of Graves' disease patients through the gut-thyroid axis. GD
33  2021 Risk factors for Graves' Orbitopathy in surgical patients-Results of a 10-year retrospective study with review of the literature. GD, GO, TPOAb
34  2021 Steroid-Resistant Graves' Orbitopathy Treated with Tocilizumab in Real-World Clinical Practice: A 9-Year Single-Center Experience. CAS, GO
35  2021 The effect of radioiodine treatment on the characteristics of TRAb in Graves' disease. AITDs, GD, RAI, TBAb, TPOAb, TSAb
36  2021 THYROTROPIN-RECEPTOR ANTIBODIES, IMMUNOGLOBULIN E AND ANTINUCLEAR ANTIBODIES IN PATIENTS WITH GRAVES' DISEASE AND GRAVES' ORBITOPATHY. ANA, GD, GO, HC, IgE, TBII
37  2020 Basedow's disease with associated features of Hashimoto's thyroiditis based on histopathological findings. TgAb, TPOAb, TSAb
38  2020 Clinical features and predictors of remission in children under the age of 7 years with Graves' disease. GD, TPOAb
39  2020 Concurrent Graves' Disease and TSH Secreting Pituitary Adenoma Presenting Suppressed Thyrotropin Levels: A Case Report and Review of the Literature. GD, TSH
40  2020 Elevated Immunoglobulin G4 Levels in Patients with Thyroid Eye Disease and Their Clinical Implications. BCVA, CAS, IgG4, TED
41  2020 Factors associated with severity of orbitopathy in patients with Graves' disease. CAS, GD, GO, IOP, ULN
42  2020 Impact of Radioiodine Treatment on Doppler Flow Parameters in the Central Retinal Artery and Ophthalmic Artery in Patients With Hyperthyroidism. CRA, EDV, OA, RI
43  2020 Measurement of anti-TSH receptor antibodies: what is the correct cut-off value? ---
44  2020 Preoperative plasmapheresis experience in Graves' disease patients with anti-thyroid drug-induced hepatotoxicity. ATI, TPE
45  2020 Scintigraphy evaluation of hyperthyroidism and its correlation with clinical and biochemical profiles. ---
46  2020 Serum concentrations of TNF-alpha and its soluble receptors in Graves' disease. GD, sTNFRs, TNF-alpha, TSH
47  2020 Significant cardiac disease complicating Graves' disease in previously healthy young adults. AF, HF
48  2020 The Potential Link between Gut Microbiota and Serum TRAb in Chinese Patients with Severe and Active Graves' Orbitopathy. GO, OTUs
49  2020 The Role of Thyroid Hormones and Autoantibodies in Metabolic Dysfunction Associated Fatty Liver Disease: TgAb May Be a Potential Protective Factor. hs-CRP, MAFLD, TgAb, THs, TPOAb, TSH
50  2020 THYROID ACROPACHY: A RARE MANIFESTATION OF GRAVES DISEASE IN JOINTS. FT4, GD, TSH
51  2020 [Application of the superior thyroid artery peak systolic velocity in differentiating Graves' disease from autoimmune thyroiditis]. AIT, AUC, GD, ROC, STA-PSV
52  2019 A pilot study on the beneficial effects of additional selenium supplementation to methimazole for treating patients with Graves’ disease GD, MMI, Se, TgAb, TPOAb
53  2019 Evaluation of Vitamin D Status and its Impact on Thyroid Related Parameters in New Onset Graves' Disease- A Cross-sectional Observational Study. OR, PTH, TSH, VDD
54  2019 Severe unilateral orbitopathy in a patient with Hashimoto's thyroiditis - a case report. CAS, GD, HT, MRI, TAO
55  2018 A patient-specific treatment model for Graves' hyperthyroidism. MMI, TSH
56  2018 Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves' disease. EGD, TAO, TBII, TSAb
57  2018 Does rituximab improve clinical outcomes of patients with thyroid-associated ophthalmopathy? A systematic review and meta-analysis. CAS, GRADE, IL-6, NOS, RTX, SMD, TAO, TSH
58  2018 Elevated Interleukin-36alpha And CD4+IL-36alpha+T Cells Are Involved in the Pathogenesis of Graves' Disease. ELISA, GD, NC, PBMCs, qRT-PCR
59  2018 Estradiol Affects Epstein-Barr Virus Reactivation-Induced Thyrotropin Receptor Antibody and Immunoglobulin Production in Graves' Disease Patients and Healthy Controls. EBV, IgG, IgM, PBMCs
60  2018 Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine Therapy. GD, NH, RAI
61  2018 Maternal Thyrotropin Receptor Antibody Concentration and the Risk of Fetal and Neonatal Thyrotoxicosis: A Systematic Review. ---
62  2018 Predicting outcomes and complications following radioiodine therapy in Graves' thyrotoxicosis. RAI, TED
63  2018 Prediction of Neonatal Hyperthyroidism. TSH
64  2018 Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy. GD, TED
65  2018 Thyrotropin receptor antibodies and a genetic hint in antithyroid drug-induced adverse drug reactions. ADRs, ATDs, GD
66  2018 Thyrotropin receptor antibody: A novel risk indicator for pregnancy loss. ROC, TSH
67  2018 Vitamin D in Graves Disease: Levels, Correlation with Laboratory and Clinical Parameters, and Genetics. DBP, GD, GO, SNPs, VDR
68  2018 [Atypical subacute thyroiditis in combination with Grave's disease:Diagnostic difficulties in a case report]. ---
69  2017 DYNAMIC CHANGES OF TRAb AND TPOAb AFTER RADIOIODINE THERAPY IN GRAVES' DISEASE. GD, RAI, TPOAb, TSH
70  2017 Optimal iodine supplementation during antithyroid drug therapy for Graves' disease is associated with lower recurrence rates than iodine restriction. ATD, FT3, FT4, GD, UIC
71  2017 Risk Factors Associated with the Activity and Severity of Graves' Ophthalmopathy among Patients at the University of the Philippines Manila-Philippine General Hospital. GD, GO, UIE
72  2017 Risk factors of hepatic dysfunction in patients with Graves' hyperthyroidism and the efficacy of 131iodine treatment. ALP
73  2017 Role of the tumour necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in autoimmune thyroid disease. AITD, Fn14, GD, HCs, HT, PBMCs, sCD163, sTWEAK, TWEAK, TWEAK
74  2017 Serum miR-146a, miR-155, and miR-210 as potential markers of Graves' disease. AUC, GD
75  2017 The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease. CTLA-4, GD, Treg, TSHR
76  2016 Clinical efficacy of combined rituximab treatment in a woman with severe Graves' ophthalmopathy. GD, GO, RTX
77  2016 Common phenotype and different non-HLA genes in Graves' disease and alopecia areata. AA, GD
78  2016 Does Immunosuppressive Therapy Improve Outcomes in Graves' Disease? A Systematic Review and Meta-Analysis. CI
79  2016 Graves' disease in 2.5 years old girl - 6-years-long observation. ---
80  2016 Irisin and Myostatin Levels in Patients with Graves' Disease. BMI, GD, TSH
81  2016 Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China. BTD, HT, PTC, TgAb
82  2016 Predicting relapse of Graves' disease following treatment with antithyroid drugs. FT, GD
83  2016 Risk Factors of Lymphnode Metastasis in Patients with Thyroid Papillary Carcinoma Associated with Graves Disease. ---
84  2016 Short and long-term effects of high-dose intravenous methylprednisolone pulse therapy on thyroid-associated ophthalmopathy. CAS, IVMP, TAO
85  2016 Thyrotropin Receptor Antibody (TRAb)-IgM Levels Are Markedly Higher Than TRAb-IgG Levels in Graves' Disease Patients and Controls, and TRAb-IgM Production Is Related to Epstein-Barr Virus Reactivation. EBV, TRAbs
86  2016 Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves Disease. ATD, TBII, TSAb
87  2015 Characterization and clinical relevance of circulating CD4+CD28- T cells in Graves' disease. GD, GO, PBMC, TSH
88  2015 Correlation between single nucleotide polymorphism of FCRL-3 gene and Graves' disease in Han population of northern Anhui province, China. GD, SNP, TgAb, TPOAb
89  2015 Differentiation between Graves' disease and painless thyroiditis by diffusion-weighted imaging, thyroid iodine uptake, thyroid scintigraphy and serum parameters. ADC, DWI, GD, NPV, PPV, PT, RAIU, ROC
90  2015 IGF1 deficiency in newly diagnosed Graves' disease patients. ATA, GD, GO, TPOAb
91  2015 Kinetic analyses of changes in serum TSH receptor antibody values after total thyroidectomy in patients with Graves' disease. GO
92  2015 [Effect of Jiakangning Capsule on Thyroid Function and Akt/mTOR Signal Pathway of Graves' Disease Mice: an Experimental Study]. GD, JC, mTOR, p-mTOR, TSH
93  2014 Hepatic dysfunction related to thyrotropin receptor antibody in patients with Graves' disease. GD, HDF, NHF
94  2014 Increased expression of IL-37 in patients with Graves' disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells. ELISA, GD, HC, IL-37, PBMCs, RT-PCR
95  2014 Long-term outcomes of pediatric Graves' disease. ATDs, GD
96  2014 Low Vitamin D Status is Associated with Increased Thyrotropin-Receptor Antibody Titer in Graves Disease. GD, PTH, TgAb, TPOAb, TSH
97  2014 Management of neonates born to women with Graves' disease: a cohort study. ATD, GD, ve
98  2014 Risk factors of hyperthyroidism with hepatic function injury: a 4-year retrospective study. GD, sTSH, TgAb
99  2014 The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases. AITD, Gc, GD, HD, PCR-RFLP, VDR
100  2014 Therapeutic effectiveness of potassium iodine in drug-naive patients with Graves' disease: a single-center experience. MMI, PS